Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Dow
Harvard Business School
AstraZeneca
Baxter

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Naphazoline hydrochloride; pheniramine maleate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for naphazoline hydrochloride; pheniramine maleate and what is the scope of patent protection?

Naphazoline hydrochloride; pheniramine maleate is the generic ingredient in four branded drugs marketed by Akorn Inc, Altaire Pharms Inc, Alcon, Bausch And Lomb, and Johnson And Johnson, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for naphazoline hydrochloride; pheniramine maleate. Seventeen suppliers are listed for this compound.

Summary for naphazoline hydrochloride; pheniramine maleate
Recent Clinical Trials for naphazoline hydrochloride; pheniramine maleate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EMSPhase 3

See all naphazoline hydrochloride; pheniramine maleate clinical trials

US Patents and Regulatory Information for naphazoline hydrochloride; pheniramine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson VISINE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 020485-001 Jan 31, 1996 OTC Yes Yes   Start Trial   Start Trial   Start Trial
Altaire Pharms Inc NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 078208-001 Sep 27, 2010 OTC No No   Start Trial   Start Trial   Start Trial
Bausch And Lomb OPCON-A naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 020065-001 Jun 8, 1994 OTC Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
McKesson
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.